Published in Gene Therapy Weekly, January 13th, 2000
"Natural killer-like T lymphocytes termed cytokine-induced killer (CIK) cells have been shown to eradicate established tumors in a severe combined immune deficient (SCID) mouse/human lymphoma model," wrote I.G.H. Schmidtwolf and colleagues from Humboldt University, Division Hematological Oncology, Germany. "Recently, we demonstrated that CIK cells transfected with cytokine genes possess an improved...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Gene Therapy Weekly